Volume V, Issue 44

Oct. 29, 2018
Amgen Cuts Repatha's Price 60% as Scrutiny of Drug Costs Heats Up   
Patrice Wendling reports for Medscape on October 24, 2018:
Amgen announced today it is lowering the cost of its cholesterol-lowering drug, evolocumab ( Repatha), by roughly 60%. The move was designed to increase demand by lowering out-of-pocket costs, especially for Medicare patients, who currently pay between $280 and $370 a month in out-of-pocket costs, but will now pay $25 to $150 a month, Amgen officials said in a telephone press briefing.
The new pricing decision comes as the White House is calling for greater transparency and lower drug prices, although Amgen officials deny pressure from President Trump was a factor in the decision.
Log in/complimentary registration required.
Geography matters in hospital quality, Healthgrades report shows
Meg Bryant reports for Healthcare Dive on 10.23.18:
Healthgrades assessed 4,500 short-term acute care hospitals and their performance on 32 common conditions and procedures. Rochester, Minnesota topped the list of healthiest cities in terms of access to care, quality hospitals and other measures in Healthgrades' National Health Index of American Cities, with Orlando, Florida, coming in last. 
Patients treated at five-star hospitals have a lower risk of dying and a lower risk of experiencing one or more complications during a hospital stay than patients treated at one-star facilities. 
Report: Growing proportion of healthcare payments tied to value
The percentage of health care payments in the US tied to value instead of volume rose from 23% in 2015 to 34% last year, according to a Health Care Payment Learning and Action Network report released 10.22.18. Nearly 50% of Medicare Advantage payments in 2017 were linked to value, compared with 38% in Medicare fee-for-service plans, 28% in commercial plans and 25% in Medicaid, according to the report.
Value based reimbursements are not a fad. Slow adopters are on notice: it is time embrace change or retire.
Inform  Connect  Engag e



About Us
Florida Health Industry Week in Review is published every Monday by

Each Monday morning, we share the top healthcare headlines of the previous week and summarize
What Happened (WH) and
Why It Matters (WIM).

To learn how you can join our team of editorial contributors, contact Jeffrey Herschler .

Inside FloridaHealthIndustry.com